Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.

[1]  S. Homer-Vanniasinkam,et al.  Penetrating atherosclerotic ulcers of the aorta , 2001, The British journal of surgery.

[2]  N. Mckie,et al.  The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. , 1998, Biochemical and biophysical research communications.

[3]  G. Angelini,et al.  Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. , 1998, Human gene therapy.

[4]  M. Bennett,et al.  Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. , 1998, Circulation research.

[5]  G. D. De Meyer,et al.  RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. , 1998, The American journal of pathology.

[6]  E. Dejana,et al.  Differential Localization of VE- and N-Cadherins in Human Endothelial Cells: VE-Cadherin Competes with N-Cadherin for Junctional Localization , 1998, The Journal of cell biology.

[7]  A. Baker,et al.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.

[8]  P. Carmeliet,et al.  Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice , 1998, The Journal of cell biology.

[9]  P. Carmeliet,et al.  Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation , 1997, Nature Genetics.

[10]  Sanjay S. Srivatsa,et al.  Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury1 , 1997 .

[11]  W. Stetler-Stevenson,et al.  Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. , 1997, Circulation.

[12]  P. Carmeliet,et al.  Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. , 1997, Circulation.

[13]  Hisahiro Yu,et al.  Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. , 1997, Hypertension.

[14]  M. Laakso,et al.  VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. , 1997, Human gene therapy.

[15]  C L Seidel,et al.  Cellular heterogeneity of the vascular tunica media. Implications for vessel wall repair. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  P. Libby,et al.  The unstable atheroma. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[17]  S. Schwartz,et al.  Monoclonality of smooth muscle cells in human atherosclerosis. , 1997, The American journal of pathology.

[18]  M. Frid,et al.  Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  A. Zalewski,et al.  Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. , 1997, Circulation.

[20]  J. Thyberg,et al.  Phenotypic Modulation of Smooth Muscle Cells after Arterial Injury Is Associated with Changes in the Distribution of Laminin and Fibronectin , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  J. Pouysségur,et al.  Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts , 1997, Oncogene.

[22]  A. Newby,et al.  Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. , 1997, Atherosclerosis.

[23]  E. Anggard,et al.  Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. , 1997, Atherosclerosis.

[24]  A. Newby,et al.  Molecular and cell biology of native coronary and vein-graft atherosclerosis: regulation of plaque stability and vessel-wall remodelling by growth factors and cell-extracellular matrix interactions. , 1997, Coronary artery disease.

[25]  P. Libby,et al.  Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  S. George,et al.  Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. , 1997, Cardiovascular research.

[27]  James M. Roberts,et al.  Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.

[28]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[29]  M. Davies,et al.  Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. , 1996, Circulation research.

[30]  P. Kovanen,et al.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. , 1996, Circulation.

[31]  S. George,et al.  Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. , 1996, Current opinion in cardiology.

[32]  A. Zalewski,et al.  Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. , 1996, Circulation.

[33]  Richard T. Lee,et al.  Macrophages and atherosclerotic plaque stability , 1996, Current opinion in lipidology.

[34]  A. Clowes,et al.  Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. , 1996, Circulation research.

[35]  S. Hughes.  Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. , 1996, Cardiovascular research.

[36]  S. Schwartz,et al.  Differential expression of alpha 1 type VIII collagen in injured platelet-derived growth factor-BB--stimulated rat carotid arteries. , 1996, Circulation research.

[37]  M. Davies,et al.  Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. , 1996, Circulation.

[38]  P. Shah,et al.  Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[39]  K. Burnand,et al.  Upregulation of IGF‐I and collagen I mRNA in human atherosclerotic tissue is not accompanied by changes in type 1 IGF receptor or collagen III mRNA: an in situ hybridization study , 1996, Coronary artery disease.

[40]  J. Wilcox,et al.  Potential role of the adventitia in arteritis and atherosclerosis. , 1996, International journal of cardiology.

[41]  G. D. De Meyer,et al.  Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. , 1996, The American journal of pathology.

[42]  A. J. Fuenmayor,et al.  Heart rate and heart rate variability changes induced by right atrial pacing. , 1996, International journal of cardiology.

[43]  A. Newby,et al.  Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. , 1996, The Biochemical journal.

[44]  K. Polyak.  Negative regulation of cell growth by TGFβ , 1996 .

[45]  C. Alpers,et al.  Platelet-derived growth factor-A mRNA expression in fetal, normal adult, and atherosclerotic human aortas. Analysis by competitive polymerase chain reaction. , 1996, Circulation.

[46]  M. Reidy,et al.  Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. , 1996, Circulation research.

[47]  R. Leeuwen.  Extracellular proteolysis and the migrating vascular smooth muscle cell , 1996 .

[48]  C. Turner,et al.  Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled , 1996, The Journal of clinical investigation.

[49]  B. Björkerud,et al.  Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[50]  M. Bennett,et al.  Is vascular smooth muscle cell proliferation beneficial? , 1996, The Lancet.

[51]  K. Malarkey,et al.  The role of protein kinase C in activation and termination of mitogen-activated protein kinase activity in angiotensin II-stimulated rat aortic smooth-muscle cells. , 1996, Cellular signalling.

[52]  S. George,et al.  An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro. , 1996, Atherosclerosis.

[53]  P. Shah,et al.  Pathophysiology of plaque rupture and the concept of plaque stabilization. , 1996, Cardiology clinics.

[54]  T. Helgason,et al.  Differentiated vascular myocytes: are they involved in neointimal formation? , 1996, The Journal of clinical investigation.

[55]  M. Heim,et al.  The Jak–STAT pathway: specific signal transduction from the cell membrane to the nucleus , 1996, European journal of clinical investigation.

[56]  T. McCaffrey,et al.  Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. , 1995, The Journal of clinical investigation.

[57]  T. Wight,et al.  The extracellular matrix and atherosclerosis , 1995, Current opinion in lipidology.

[58]  E. Lakatta,et al.  Intracellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor. , 1995, The Journal of clinical investigation.

[59]  I. Zachary,et al.  Signalling mechanisms in the regulation of vascular cell migration. , 1995, Cardiovascular research.

[60]  M. Ferguson,et al.  Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. , 1995, Circulation.

[61]  S M Schwartz,et al.  The intima. Soil for atherosclerosis and restenosis. , 1995, Circulation research.

[62]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Circulation.

[63]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[64]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[65]  J. Isner,et al.  Apoptosis in human atherosclerosis and restenosis. , 1995, Circulation.

[66]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[67]  P. Weissberg,et al.  Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta. , 1995, Cardiovascular research.

[68]  G. Evan,et al.  Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[69]  C. Parish,et al.  Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: Evidence for cytokine dependence and detection of a novel sulfatase , 1995, Immunology and cell biology.

[70]  M. Kowala,et al.  Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. , 1995, The American journal of pathology.

[71]  A. Banning,et al.  Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation. , 1995, Experimental nephrology.

[72]  D. Nance,et al.  Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. , 1995, The Journal of clinical investigation.

[73]  P. Kelly,et al.  Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. , 1995, Circulation.

[74]  W. Cowden,et al.  Differential effects of the anti‐inflammatory compounds heparin, mannose‐6‐phosphate, and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells, and platelets , 1995, Journal of leukocyte biology.

[75]  R. Ross,et al.  The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. , 1995, The Journal of clinical investigation.

[76]  D. Gordon,et al.  Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. , 1995, Circulation research.

[77]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[78]  P. Libby,et al.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[79]  S. L. Brown,et al.  Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis. , 1994, Cardiovascular research.

[80]  J. Campbell,et al.  An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbit. , 1994, Clinical science.

[81]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[82]  H. Deckmyn,et al.  Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. , 1994, Circulation.

[83]  R. Ross,et al.  Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. , 1994, The American journal of pathology.

[84]  A. Clowes,et al.  Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. , 1994, Circulation research.

[85]  G. Evan,et al.  Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? , 1994, The Biochemical journal.

[86]  M. Reidy,et al.  Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.

[87]  A. Braverman.  Penetrating atherosclerotic ulcers of the aorta , 1994, Current opinion in cardiology.

[88]  M. Rekhter,et al.  Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. , 1994, Journal of vascular research.

[89]  M. Reidy,et al.  Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. , 1994, Journal of vascular surgery.

[90]  J. Seki,et al.  Effect of TFC-612, a 7-thia prostaglandin E1 derivative, on intimal thickening after endothelial injury with balloon catheter in rats. , 1994, Atherosclerosis.

[91]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[92]  D. Morris,et al.  Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. , 1994, Circulation research.

[93]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[94]  E. Lakatta,et al.  Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. , 1994, Circulation research.

[95]  P. Kovanen,et al.  Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[96]  M. Shiomi,et al.  Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. An immunohistochemical study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[97]  A. Clowes,et al.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. , 1994, The Journal of clinical investigation.

[98]  E. Ruoslahti,et al.  Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. , 1994, The Journal of clinical investigation.

[99]  G. Evan,et al.  Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. , 1994, Circulation research.

[100]  E. Krebs,et al.  Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. , 1994, The Journal of clinical investigation.

[101]  B. Björkerud,et al.  Lipoproteins are major and primary mitogens and growth promoters for human arterial smooth muscle cells and lung fibroblasts in vitro. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[102]  M A Schork,et al.  Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. , 1993, The American journal of pathology.

[103]  E. Krebs,et al.  Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[104]  W. Thompson,et al.  Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques. , 1993, Atherosclerosis.

[105]  G. Angelini,et al.  Surgical preparation induces injury and promotes smooth muscle cell proliferation in a culture of human saphenous vein. , 1993, Cardiovascular research.

[106]  R. Poston,et al.  The immunohistochemical heterogeneity of atheroma macrophages: comparison with lymphoid tissues suggests that recently blood-derived macrophages can be distinguished from longer-resident cells. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[107]  U. Ryan,et al.  Thrombospondin mediates migration and potentiates platelet‐derived growth factor‐dependent migration of calf pulmonary artery smooth muscle cells , 1993, Journal of cellular physiology.

[108]  C. Alpers,et al.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.

[109]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate , 1993, The Journal of cell biology.

[110]  D A Lauffenburger,et al.  Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength , 1993, The Journal of cell biology.

[111]  R. Ross,et al.  Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[112]  S. Gilbertson-Beadling,et al.  A potential role for N-cadherin in mediating endothelial cell-smooth muscle cell interactions in the rat vasculature. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[113]  P L Weissberg,et al.  Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. , 1993, Circulation research.

[114]  S. George,et al.  Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. , 1993, Cardiovascular research.

[115]  L. Kuo,et al.  Dietary-induced atherosclerotic lesions have increased levels of acidic FGF mRNA and altered cytoskeletal and extracellular matrix mRNA expression. , 1993, Journal of vascular research.

[116]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[117]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[118]  M. Reidy,et al.  The Role of Plasminogen Activation in Smooth Muscle Cell Migration after Arterial Injury , 1992, Annals of the New York Academy of Sciences.

[119]  M. Hallett,et al.  Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. , 1992, The Biochemical journal.

[120]  N. Morisaki,et al.  Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. , 1992, The Journal of biological chemistry.

[121]  A. Newby,et al.  Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. , 1992, The Biochemical journal.

[122]  Thiennu H. Vu,et al.  Thrombin receptor expression in normal and atherosclerotic human arteries. , 1992, The Journal of clinical investigation.

[123]  J. Isner,et al.  Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. , 1992, The Journal of clinical investigation.

[124]  Ward Casscells,et al.  Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis , 1992, Circulation.

[125]  G. Angelini,et al.  Time-course of medial and intimal thickening in pig venous arterial grafts: relationship to endothelial injury and cholesterol accumulation. , 1992, The Journal of thoracic and cardiovascular surgery.

[126]  A. Clowes,et al.  Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. , 1992, Circulation research.

[127]  N. Olson,et al.  Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. , 1992, The American journal of pathology.

[128]  M. Reidy,et al.  Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. , 1991, The American journal of pathology.

[129]  S. Coughlin,et al.  Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.

[130]  A. Henney,et al.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[131]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[132]  G. Hansson,et al.  Interferon-gamma inhibits arterial stenosis after injury. , 1991, Circulation.

[133]  U. Hedin,et al.  Thrombin-inhibitory capacity of the injured vessel wall. , 1991, Thrombosis research.

[134]  G. Trinchieri,et al.  Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[135]  M. Reidy,et al.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[136]  M. Meltzer,et al.  Tumor necrosis factor. , 1991, Journal of the American Academy of Dermatology.

[137]  M. Kuzuya,et al.  Vitronectin-induced haptotaxis of vascular smooth muscle cells in vitro. , 1991, Experimental cell research.

[138]  V. Fuster,et al.  Antithrombotic therapy in the coronary vein graft patient , 1991, Clinical cardiology.

[139]  M. Davies,et al.  Atherosclerotic plaque caps are locally weakened when macrophages density is increased. , 1991, Atherosclerosis.

[140]  R. Cardell,et al.  Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. , 1991, The American journal of pathology.

[141]  N. Morisaki,et al.  Secretion of a potent new migration factor for smooth muscle cells (SMC) by cultured SMC. , 1991, Atherosclerosis.

[142]  G. Angelini,et al.  Smooth muscle cell proliferation in response to injury in an organ culture of human saphenous vein , 1991 .

[143]  J. Thyberg,et al.  Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.

[144]  M. Reidy,et al.  Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. , 1990, Arteriosclerosis.

[145]  R. Derynck,et al.  Transforming growth factor‐α , 1990, Molecular reproduction and development.

[146]  U. Garg,et al.  Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism. , 1990, Biochemical and biophysical research communications.

[147]  D. Belin,et al.  Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. , 1990, Circulation research.

[148]  S. Schwartz,et al.  Cell proliferation in human coronary arteries. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[149]  A. Gown,et al.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis. , 1990, Science.

[150]  M. Territo,et al.  Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. , 1990, The Journal of clinical investigation.

[151]  R. Ross,et al.  Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. , 1990, Arteriosclerosis.

[152]  R. Ross,et al.  Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. , 1990, Arteriosclerosis.

[153]  Julie H. Campbell,et al.  Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. , 1990, The Biochemical journal.

[154]  K. Kariya,et al.  Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. , 1989, Atherosclerosis.

[155]  W. Roberts,et al.  Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. , 1989, Circulation.

[156]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[157]  G. Gabbiani,et al.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells , 1989, The Journal of experimental medicine.

[158]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[159]  J. Thyberg,et al.  A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. , 1989, Developmental biology.

[160]  A. Gotlieb,et al.  Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture. , 1989, The American journal of pathology.

[161]  O. Ornatsky,et al.  Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[162]  J. Pober.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. , 1988, The American journal of pathology.

[163]  L. Matrisian,et al.  Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. , 1988, The Journal of biological chemistry.

[164]  D. Ku,et al.  Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. , 1988, Archives of pathology & laboratory medicine.

[165]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[166]  J. Pepper,et al.  Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. , 1988, British heart journal.

[167]  J. Thyberg,et al.  Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.

[168]  C. Heldin,et al.  INDUCTION OF B-TYPE RECEPTORS FOR PLATELET-DERIVED GROWTH FACTOR IN VASCULAR INFLAMMATION: POSSIBLE IMPLICATIONS FOR DEVELOPMENT OF VASCULAR PROLIFERATIVE LESIONS , 1988, The Lancet.

[169]  G. Harsh,et al.  Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells. , 1988, The Journal of biological chemistry.

[170]  P. Libby,et al.  Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.

[171]  T. Barrett,et al.  Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[172]  V. Koteliansky,et al.  Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. , 1987, Atherosclerosis.

[173]  W. Thompson,et al.  Mitogenic activity in human atherosclerotic lesions. , 1987, Atherosclerosis.

[174]  P. Bornstein,et al.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[175]  V. Tertov,et al.  Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. , 1986, The American journal of pathology.

[176]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[177]  A. Penn,et al.  Transforming gene in human atherosclerotic plaque DNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[178]  O. Kocher,et al.  Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. , 1986, Human pathology.

[179]  A. Clowes,et al.  Kinetics of Cellular Proliferation after Arterial Injury: IV. Heparin Inhibits Rat Smooth Muscle Mitogenesis and Migration , 1986, Circulation research.

[180]  K. Murata,et al.  Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. , 1986, Atherosclerosis.

[181]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[182]  S. Schwartz,et al.  Replication of smooth muscle cells in vascular disease. , 1986, Circulation research.

[183]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[184]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[185]  R. Ross,et al.  A significant part of macrophage-derived growth factor consists of at least two forms of PDGF , 1985, Cell.

[186]  S. Schwartz,et al.  Kinetics of Atherosclerosis: A Stem Cell Model , 1985, Annals of the New York Academy of Sciences.

[187]  H. Waldmann,et al.  Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies , 1985, The Journal of pathology.

[188]  P. Libby,et al.  Lipoproteins increase growth of mitogen‐stimulated arterial smooth muscle cells , 1985, Journal of cellular physiology.

[189]  D. Klurfeld,et al.  Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. , 1985, Archives of pathology & laboratory medicine.

[190]  S. Schwartz,et al.  Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.

[191]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque , 1984, Arteriosclerosis.

[192]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.

[193]  V. Tertov,et al.  Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. , 1984, The American journal of pathology.

[194]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[195]  Thomas Wa,et al.  Biology of disease. Atherosclerosis as a hyperplastic and/or neoplastic process. , 1983 .

[196]  V. Hascall,et al.  Proteoglycans in primate arteries. III. Characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture , 1983, The Journal of cell biology.

[197]  T. Kita,et al.  Cellular Pathology of Progressive Atherosclerosis in the WHHL Rabbit: An Animal Model of Familial Hypercholesterolemia , 1983, Arteriosclerosis.

[198]  J. Chamley-Campbell,et al.  What controls smooth muscle phenotype? , 1981, Atherosclerosis.

[199]  C. Velican,et al.  The precursors of coronary atherosclerotic plaques in subjects up to 40 years old. , 1980, Atherosclerosis.

[200]  Y. Watanabe.  Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). , 1980, Atherosclerosis.

[201]  T. Pearson,et al.  The human atherosclerotic plaque. , 1977, The American journal of pathology.

[202]  G. Hutchins,et al.  Accelerated “Atherosclerosis” A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts: A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts , 1977, Circulation.

[203]  E. Benditt,et al.  Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. , 1975, The American journal of pathology.

[204]  R. Ross,et al.  Atherosclerosis and the Arterial Smooth Muscle Cell , 1973 .

[205]  E. Benditt,et al.  Evidence for a monoclonal origin of human atherosclerotic plaques. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[206]  Arterioscler Thromb,et al.  Arteriosclerosis , 1925, Steinkopff.

[207]  J. Padmanabhan,et al.  Flow cytometric analysis of nitric oxide production in human neutrophils using dichiorofluorescein diacetate in the presence of a calmodulin inhibitor , 2005 .

[208]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[209]  B. Gumbiner,et al.  Molecular and functional analysis of cadherin-based adherens junctions. , 1997, Annual review of cell and developmental biology.

[210]  E. Lakatta,et al.  Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. , 1996, The American journal of pathology.

[211]  K. Polyak.  Negative regulation of cell growth by TGF beta. , 1996, Biochimica et biophysica acta.

[212]  A. Clowes,et al.  Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[213]  J. Thyberg.  Differentiated properties and proliferation of arterial smooth muscle cells in culture. , 1996, International review of cytology.

[214]  M. Reidy,et al.  Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. , 1996, Circulation research.

[215]  P. Libby,et al.  Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque , 1995, Journal of cardiovascular pharmacology.

[216]  K. Rogers,et al.  Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2: Differing morphological severity of atherogenesis despite matched plasma cholesterol levels. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[217]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[218]  S. Coughlin,et al.  Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. , 1993, The Journal of clinical investigation.

[219]  M. Waters,et al.  of Insulin-Like Growth , 1993 .

[220]  G. Hansson,et al.  Can immunocompetent cells and their cytokines play a role in atherogenesis? , 1992, Nouvelle revue francaise d'hematologie.

[221]  H. C. Stary,et al.  The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. , 1990, European heart journal.

[222]  T. Wight,et al.  Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.

[223]  J. Kishi,et al.  Synthesis of latent collagenase and collagenase inhibitor by bovine aortic medial explants and cultured medial smooth muscle cells. , 1989, Connective tissue research.

[224]  W. Ansorge,et al.  Negative Regulation of Cell Growth , 1989 .

[225]  J. Fingerle,et al.  The induction of smooth muscle cell proliferation in vitro using an organ culture system. , 1987, International angiology : a journal of the International Union of Angiology.

[226]  J. Campbell,et al.  Endothelial cell influences on vascular smooth muscle phenotype. , 1986, Annual review of physiology.

[227]  J. Vandekerckhove,et al.  Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. , 1984, The Journal of clinical investigation.

[228]  Stehbens We,et al.  Hemodynamics and atherosclerosis. , 1982, Biorheology.

[229]  M. Horwitz,et al.  in Human Monocytes , 1980 .

[230]  M. Reidy,et al.  Basic Fibroblast Growth Factor Stimulates Endothelial Regrowth and Proliferation in Denuded Arteries , 2022 .